Wound-healing spray moves to Phase III clinical trials

04/16/2013 | WTAJ-TV (Altoona, Pa.)

Patients are being recruited for Phase III clinical trials of a spray containing human cells that release growth factors into a wound to encourage tissue regeneration. Wounds treated with the spray were 52% more likely to heal than those treated with compression bandages in earlier trials.

View Full Article in:

WTAJ-TV (Altoona, Pa.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD